Cambridge Epigenetix secures US$ 88 million series D financing to enhance DNA sequence technology platform

by | Nov 5, 2021 | , , , , | 0

UNITED KINGDOM – Cambridge Epigenetix (CEGX), a life sciences tools and technology company...

Read More